Correlation Between Visa and DOD Biotech
Can any of the company-specific risk be diversified away by investing in both Visa and DOD Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and DOD Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and DOD Biotech Public, you can compare the effects of market volatilities on Visa and DOD Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of DOD Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and DOD Biotech.
Diversification Opportunities for Visa and DOD Biotech
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Visa and DOD is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and DOD Biotech Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOD Biotech Public and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with DOD Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOD Biotech Public has no effect on the direction of Visa i.e., Visa and DOD Biotech go up and down completely randomly.
Pair Corralation between Visa and DOD Biotech
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.48 times more return on investment than DOD Biotech. However, Visa Class A is 2.08 times less risky than DOD Biotech. It trades about 0.28 of its potential returns per unit of risk. DOD Biotech Public is currently generating about -0.36 per unit of risk. If you would invest 27,442 in Visa Class A on August 30, 2024 and sell it today you would earn a total of 4,028 from holding Visa Class A or generate 14.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Visa Class A vs. DOD Biotech Public
Performance |
| Timeline |
| Visa Class A |
| DOD Biotech Public |
Visa and DOD Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and DOD Biotech
The main advantage of trading using opposite Visa and DOD Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, DOD Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOD Biotech will offset losses from the drop in DOD Biotech's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| DOD Biotech vs. Carabao Group Public | DOD Biotech vs. Jay Mart Public | DOD Biotech vs. Gulf Energy Development | DOD Biotech vs. KCE Electronics Public |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |